India to United Arab Emirates: Ustekinumab Export Trade Route
India has recorded 4 verified shipments of Ustekinumab exported to United Arab Emirates, representing a combined trade value of $19.1K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $4.8K USD. The leading Indian exporter is ANR HEALTH CARE PRIVATE LIMITED, which accounts for 94% of total export value with 3 shipments worth $17.9K USD. On the buying side, DAWAA DRUG STORE LLC is the largest importer in United Arab Emirates with $17.9K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United Arab Emirates Ustekinumab corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $19.1K USD. The route is dominated by ANR HEALTH CARE PRIVATE LIMITED, which alone accounts for roughly 94% of all export value, reflecting the consolidated nature of India's ustekinumab manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $4.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 17.4%, placing it at rank #12 among India's top ustekinumab export destinations globally.
On the import side, key buyers of Indian ustekinumab in United Arab Emirates include DAWAA DRUG STORE LLC, PRANJAL PATIL. DAWAA DRUG STORE LLC is the single largest importer with 3 shipments valued at $17.9K USD.
Route Characteristics
- Average transit25 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portDELHI AIR
Market Position
- Global rank#12
- Annual growth+17.4%
- Demand growth+15.0%
- Regulatory ease68/100
Top 10 Indian Ustekinumab Exporters to United Arab Emirates
Showing top 10 of 2 Indian suppliers exporting Ustekinumab to United Arab Emirates, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ANR HEALTH CARE PRIVATE LIMITED Avg $6.0K per shipment | 3 | $17.9K | 93.8% |
| 2 | SHREE SSR GLOBALS Avg $1.2K per shipment | 1 | $1.2K | 6.2% |
This table shows the top 10 of 2 Indian companies exporting ustekinumab to United Arab Emirates, ranked by total trade value. The listed exporters are: ANR HEALTH CARE PRIVATE LIMITED, SHREE SSR GLOBALS. ANR HEALTH CARE PRIVATE LIMITED is the dominant supplier with 3 shipments worth $17.9K USD, giving it a 94% market share.
Top 10 Ustekinumab Importers in United Arab Emirates
Showing top 10 of 2 known buyers in United Arab Emirates receiving Ustekinumab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ustekinumab in United Arab Emirates include DAWAA DRUG STORE LLC, PRANJAL PATIL. The largest importer is DAWAA DRUG STORE LLC, accounting for $17.9K USD across 3 shipments — representing 94% of all ustekinumab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DAWAA DRUG STORE LLC | 3 | $17.9K | 93.8% |
| 2 | PRANJAL PATIL | 1 | $1.2K | 6.2% |
Top 10 Ustekinumab Formulations Imported by United Arab Emirates
Showing top 10 of 4 product formulations shipped on the India to United Arab Emirates Ustekinumab route, ranked by trade value
United Arab Emirates imports a wide range of ustekinumab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — STELARA 90MG/1ML USTEKINUMAB 90MG B NCS4VME M 03/23 E 02/26 — accounts for $9.0K USD across 1 shipments. A total of 4 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | STELARA 90MG/1ML USTEKINUMAB 90MG B NCS4VME M 03/23 E 02/26 | 1 | $9.0K | 46.9% |
| 2 | STELARA 90MG/1ML USTEKINUMAB 90MG B: NGS0PMD M: 07/23 E: 06/26 | 1 | $6.0K | 31.3% |
| 3 | STELARA 90MG/1ML USTEKINUMAB 90MG B NGS0PMD M 07/23 E 06/26 | 1 | $3.0K | 15.6% |
| 4 | PHARMACEUTICAL PRODUCTS Stelara 90mg Ustekinumab | 1 | $1.2K | 6.2% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 67% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
DELHI AIR handles the highest volume with 3 shipments. Transit time averages 25 days by sea.
Market Dynamics
India's ustekinumab exports to United Arab Emirates are driven primarily by a handful of large-scale manufacturers. ANR HEALTH CARE PRIVATE LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in United Arab Emirates benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — ANR HEALTH CARE PRIVATE LIMITED, SHREE SSR GLOBALS — together account for 100% of total trade value on this route. The average shipment value of $4.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as stelara 90mg/1ml ustekinumab 90mg b: ngs0pmd m: 07/23 e: 06/26 and stelara 90mg/1ml ustekinumab 90mg b ngs0pmd m 07/23 e 06/26, suggesting that buyers in United Arab Emirates tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, DAWAA DRUG STORE LLC is the largest importer with 3 shipments worth $17.9K USD — representing 94% of all ustekinumab imports from India on this route.
Route Statistics
- Trade Volume
- $19.1K
- Avg. Shipment
- $4.8K
- Suppliers
- 2
- Buyers
- 2
- Transit (Sea)
- ~25 days
- Annual Growth
- +17.4%
Related Analysis
Other Ustekinumab Routes
Unlock the Full India to United Arab Emirates Ustekinumab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 4 shipments on this route.
Frequently Asked Questions — India to United Arab Emirates Ustekinumab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ustekinumab to United Arab Emirates?
The leading Indian exporters of Ustekinumab to United Arab Emirates are ANR HEALTH CARE PRIVATE LIMITED, SHREE SSR GLOBALS. ANR HEALTH CARE PRIVATE LIMITED holds the largest market share at approximately 94% of total trade value on this route.
Q What is the total value of Ustekinumab exports from India to United Arab Emirates?
India exports Ustekinumab to United Arab Emirates worth approximately $19.1K USD across 4 recorded shipments. The average value per shipment is $4.8K USD.
Q Which ports does India use to ship Ustekinumab to United Arab Emirates?
The most active port of origin is DELHI AIR with 3 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 67% of shipments going by sea and 17% by air.
Q How long does shipping take from India to United Arab Emirates for Ustekinumab?
The average transit time for Ustekinumab shipments from India to United Arab Emirates is approximately 25 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United Arab Emirates Ustekinumab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 17.4% with demand growth tracking at 15.0%. The route is ranked #12 among India's top Ustekinumab export destinations globally.
Q How many suppliers are active on the India to United Arab Emirates Ustekinumab route?
There are currently 2 active Indian suppliers exporting Ustekinumab to United Arab Emirates. The market is moderately concentrated with ANR HEALTH CARE PRIVATE LIMITED accounting for 94% of total shipment value.
Q Who are the main importers of Ustekinumab from India in United Arab Emirates?
The leading importers of Indian Ustekinumab in United Arab Emirates include DAWAA DRUG STORE LLC, PRANJAL PATIL. DAWAA DRUG STORE LLC is the largest buyer with 3 shipments worth $17.9K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United Arab Emirates export trade corridor identified from Indian Customs (DGFT) records for Ustekinumab.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 2 importers in United Arab Emirates matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 4 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists